LPCN News and Press, Lipocine Inc. From 10/18/21

ION Geophysical (NYSE:IO) +45% sees Q3 revenues more than doubling Q/Q Valneva SE (NASDAQ:VALN) +36% after topline results from late-stage VLA2001 COVID-19 trial Adamis Pharmaceuticals (NASDAQ:ADMP) +35% after FDA approves opioid overdose treatment ZIMHI MeiraGTx...

Lipocine And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO® PR Newswire SALT LAKE CITY , Oct. 18, 2021 /PRNewswire/ -- Under the terms of Agreement Lipocine to receive: Up to $21.0 million in licensing f...

Lipocine to Present at The H.C. Wainwright 5th Annual NASH Investor Conference PR Newswire SALT LAKE CITY , Oct. 5, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders...

Lipocine Announces FDA Affirmation Of Class 1 NDA Resubmission For TLANDO® PR Newswire SALT LAKE CITY , Sept. 28, 2021 /PRNewswire/ -- Lipocine Inc. (Nasdaq: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, ...

Lipocine to Present at The Cantor Fitzgerald Virtual Global Healthcare Conference PR Newswire SALT LAKE CITY , Sept. 20, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorder...

Lipocine to Present at The H.C. Wainwright 23rd Annual Global Investment Conference PR Newswire SALT LAKE CITY , Sept. 1, 2021 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine diso...

Will These Penny Stocks on Reddit Show Momentum Next Month? With SPRT stock making headlines, many penny stocks investors are looking for the next best small-cap to buy. In addition to SPRT stock’s over 100% gain today and 1700% six month gain, many cryptocurrencies are spiking r...

Analysts Say These Are Penny Stocks To Buy Right Now; Do You Agree? Penny stocks are well-known for their high risk. But ask any trader in 2021 and you’ll also see how many look to buy these cheap stocks for their potential rewards. Just look at the last 2 weeks, for instance. We...

Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT Study Histological Analysis Demonstrates Treatment Potential of LPCN 1144 in NASH - Both LPCN 1144 treatment arms met with statistical significance the pre-specifie...

Lipocine (NASDAQ:LPCN): Q2 GAAP EPS of -$0.08 misses by $0.03. As of June 30, 2021, the Company had $46.6 million of unrestricted cash, cash equivalents, and marketable investments, compared to $19.7 million of unrestricted cash, cash equivalents and marketable investment securities as of Dec...